Index S&P 500
P/E 22.04
EPS (ttm) 2.22
Insider Own 0.43%
Shs Outstand 338.20M
Perf Week 2.01%
Market Cap 16.52B
Forward P/E 17.67
EPS next Y 2.76
Insider Trans -10.35%
Shs Float 336.88M
Perf Month 0.21%
Enterprise Value 19.51B
PEG 34.99
EPS next Q 0.57
Inst Own 100.05%
Short Float 2.28%
Perf Quarter -8.63%
Income 768.90M
P/S 2.69
EPS this Y -14.53%
Inst Trans -4.87%
Short Ratio 1.81
Perf Half Y -9.75%
Sales 6.15B
P/B 1.59
EPS next Y 10.34%
ROA 4.33%
Short Interest 7.69M
Perf YTD -13.58%
Book/sh 30.70
P/C 9.01
EPS next 5Y 0.63%
ROE 7.36%
52W High 62.77 -22.21%
Perf Year -10.11%
Cash/sh 5.42
P/FCF 11.92
EPS past 3/5Y 13.17% 3.68%
ROIC 5.79%
52W Low 45.49 7.34%
Perf 3Y -0.04%
Dividend Est. 0.32 (0.65%)
EV/EBITDA 11.65
Sales past 3/5Y 5.85% 6.43%
Gross Margin 59.78%
Volatility 2.25% 1.89%
Perf 5Y 4.46%
Dividend TTM 0.24 (0.49%)
EV/Sales 3.17
EPS Y/Y TTM -11.27%
Oper. Margin 18.42%
ATR (14) 1.05
Perf 10Y -
Dividend Ex-Date Sep 12, 2025
Quick Ratio 0.80
Sales Y/Y TTM -0.12%
Profit Margin 12.51%
RSI (14) 52.76
Recom 2.57
Dividend Gr. 3/5Y 4.55% 2.71%
Current Ratio 0.96
EPS Q/Q -11.33%
SMA20 1.48%
Beta 1.15
Target Price 57.25
Payout 13.55%
Debt/Eq 0.46
Sales Q/Q -2.16%
SMA50 -0.96%
Rel Volume 1.18
Prev Close 49.57
Employees 18000
LT Debt/Eq 0.28
Earnings Jul 30 BMO
SMA200 -9.99%
Avg Volume 4.24M
Price 48.83
IPO Jun 13, 2016
Option/Short Yes / Yes
EPS/Sales Surpr. 15.82% 0.30%
Trades
Volume 4,988,351
Change -1.49%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-02-25 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$50
Aug-14-25 Downgrade
Barclays
Overweight → Equal Weight
$54
Jul-31-25 Downgrade
Truist
Buy → Hold
$55
Jul-22-25 Downgrade
Melius
Buy → Hold
$62
Jul-15-25 Downgrade
TD Cowen
Buy → Hold
$50
Apr-09-25 Downgrade
Exane BNP Paribas
Outperform → Neutral
$67
Dec-09-24 Downgrade
Citigroup
Buy → Neutral
$92 → $86
Nov-18-24 Downgrade
Argus
Buy → Hold
Nov-13-24 Initiated
UBS
Neutral
$84
Oct-10-24 Upgrade
JP Morgan
Neutral → Overweight
$90 → $92
Sep-06-24 Upgrade
Mizuho
Neutral → Outperform
$80 → $90
Sep-06-24 Initiated
Morgan Stanley
Overweight
$89
Sep-06-24 Downgrade
Wolfe Research
Outperform → Peer Perform
Sep-05-24 Upgrade
Raymond James
Mkt Perform → Outperform
Jul-08-24 Upgrade
TD Cowen
Hold → Buy
$75 → $90
Apr-17-24 Downgrade
JP Morgan
Overweight → Neutral
$95 → $90
Mar-14-24 Initiated
Truist
Buy
$99
Jan-02-24 Downgrade
Vertical Research
Buy → Hold
Oct-26-23 Downgrade
BofA Securities
Buy → Neutral
$70
Oct-05-23 Initiated
Exane BNP Paribas
Outperform
$91
Show Previous Ratings
Sep-11-25 02:16PM
Sep-08-25 10:10AM
Sep-02-25 09:45AM
07:00AM
Aug-27-25 04:30PM
04:15PM
Loading…
04:15PM
Aug-21-25 09:39AM
Aug-19-25 09:56AM
12:40AM
Aug-13-25 02:31AM
12:31AM
Aug-12-25 11:46PM
11:39PM
12:30PM
Aug-11-25 05:00PM
10:38AM
Loading…
Aug-07-25 10:38AM
Aug-01-25 10:39AM
10:34AM
Jul-31-25 10:30AM
09:46AM
Jul-30-25 03:41PM
10:00AM
08:54AM
08:21AM
(Associated Press Finance)
07:30AM
Jul-28-25 11:17PM
Jul-23-25 10:00AM
Jul-22-25 12:07AM
Jul-21-25 08:30AM
Jul-19-25 02:37AM
10:01AM
Loading…
Jul-07-25 10:01AM
Jul-02-25 04:15PM
10:29AM
Jul-01-25 08:00AM
Jun-30-25 04:07PM
06:01AM
06:00AM
Jun-26-25 03:48AM
Jun-25-25 06:12PM
02:31AM
Jun-16-25 11:38PM
Jun-12-25 08:04AM
Jun-10-25 09:15AM
08:55AM
07:30AM
07:29AM
Jun-03-25 04:00AM
Jun-02-25 04:30PM
May-30-25 11:30AM
May-29-25 10:21AM
May-27-25 04:30PM
04:25PM
May-22-25 04:31PM
May-21-25 06:26AM
May-15-25 02:37PM
May-14-25 06:01PM
May-13-25 05:39AM
May-12-25 02:00AM
02:00AM
May-07-25 02:29PM
07:30AM
May-05-25 07:29AM
May-02-25 09:06AM
03:55AM
(Thomson Reuters StreetEvents)
03:16AM
May-01-25 06:58PM
05:55PM
09:30AM
08:40AM
07:38AM
(Associated Press Finance)
07:30AM
Apr-30-25 11:30AM
09:15AM
Apr-28-25 09:06AM
Apr-24-25 10:01AM
Apr-23-25 04:10PM
Apr-21-25 09:05AM
Apr-10-25 10:18AM
Apr-03-25 04:30PM
(Business Wire) -8.98%
-5.16%
04:15PM
Apr-02-25 10:34AM
Mar-28-25 09:46PM
Mar-18-25 05:12AM
Mar-11-25 05:03AM
Mar-10-25 09:01AM
Mar-07-25 04:15PM
Mar-05-25 04:01AM
Mar-04-25 04:15PM
08:00AM
Feb-28-25 04:06AM
04:04AM
Feb-26-25 07:30AM
Feb-19-25 09:00AM
Feb-12-25 01:59PM
Feb-11-25 04:15PM
04:15PM
Feb-08-25 03:20AM
(Thomson Reuters StreetEvents)
02:10AM
Feb-07-25 03:40PM
07:48AM
(Associated Press Finance)
Fortive Corp. engages in the design, development, manufacturing, and marketing of professional and engineered products, software, and services for a variety of end markets. It operates through the following segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides solutions to accelerate industrial and facility reliability and performance, as well as compliance and safety across a range of vertical end markets, including manufacturing, process industries, healthcare, utilities and power, communications, and electronics. The Precision Technologies segment supplies technologies such as electrical test and measurement instruments and services, energetic material devices, and a broad portfolio of sensor and control system solutions. The Advanced Healthcare Solutions segment serves healthcare customers with products and services for critical activities, including instrument and device reprocessing, instrument tracking, cell therapy equipment design and manufacturing, biomedical test tools, radiation safety monitoring, and asset management. The company was founded by James A. Lico and Stacey A. Walker on November 10, 2015 and is headquartered in Everett, WA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Okerstrom Mark D Chief Financial Officer Aug 01 '25 Buy 47.03 21,300 1,001,739 94,622 Aug 04 07:46 PM LICO JAMES A President and CEO May 15 '25 Sale 72.40 175,000 12,670,000 428,585 May 16 05:04 PM LICO JAMES A Officer May 15 '25 Proposed Sale 72.39 175,000 12,669,125 May 15 04:43 PM Underwood Peter C SVP - Chief Legal Officer May 12 '25 Sale 73.88 14,327 1,058,479 51,750 May 13 07:41 PM Underwood Peter C Officer May 12 '25 Proposed Sale 73.88 14,327 1,058,417 May 12 04:06 PM Walker Stacey A. SVP - Human Resources Feb 28 '25 Sale 79.05 3,002 237,308 42,373 Mar 04 05:21 PM McLaughlin Charles E SVP - Chief Financial Officer Feb 28 '25 Option Exercise 35.84 16,467 590,177 108,211 Mar 04 05:19 PM McLaughlin Charles E SVP - Chief Financial Officer Feb 28 '25 Sale 78.86 32,085 2,530,223 76,126 Mar 04 05:19 PM Mulhall Christopher M. VP - Chief Accounting Officer Feb 26 '25 Sale 79.95 6,493 519,115 24,283 Feb 28 06:02 PM Mulhall Christopher M. VP - Chief Accounting Officer Feb 26 '25 Sale 80.12 1,395 111,767 5,815 Feb 28 06:02 PM Walker Stacey A. SVP - Human Resources Feb 26 '25 Sale 80.52 5,688 457,998 47,141 Feb 28 06:02 PM Walker Stacey A. Officer Feb 28 '25 Proposed Sale 79.05 3,002 237,302 Feb 28 02:13 PM McLaughlin Charles E Officer Feb 28 '25 Proposed Sale 78.86 32,085 2,530,259 Feb 28 01:24 PM LICO JAMES A President and CEO Feb 24 '25 Option Exercise 35.35 335,999 11,877,853 724,968 Feb 26 07:10 PM LICO JAMES A President and CEO Feb 24 '25 Sale 80.38 196,117 15,763,884 528,851 Feb 26 07:10 PM Walker Stacey A. Officer Feb 26 '25 Proposed Sale 80.52 5,688 457,978 Feb 26 12:01 PM LICO JAMES A Officer Feb 24 '25 Proposed Sale 80.38 196,117 15,763,195 Feb 24 04:19 PM LICO JAMES A Officer Nov 15 '24 Proposed Sale 74.84 80,000 5,986,880 Nov 15 04:58 PM Underwood Peter C SVP - General Counsel Nov 11 '24 Sale 76.58 5,000 382,900 48,346 Nov 13 06:05 PM Underwood Peter C Officer Nov 11 '24 Proposed Sale 76.58 5,000 382,900 Nov 12 10:58 AM Walker Stacey A. SVP - Human Resources Nov 01 '24 Option Exercise 58.03 171,808 9,969,576 214,459 Nov 05 06:21 PM Walker Stacey A. SVP - Human Resources Nov 01 '24 Sale 71.71 171,808 12,320,352 42,651 Nov 05 06:21 PM Walker Stacey A. Officer Nov 01 '24 Proposed Sale 71.71 171,808 12,320,511 Nov 01 02:00 PM